5-methylcytosine has been researched along with Acute Liver Injury, Drug-Induced in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Feng, F; Li, Y; Ren, Q; Sun, S; Wang, X; Wu, D; Zhang, M; Zhu, H | 1 |
Fukushima, S; Kang, JS; Morimura, K; Totsuka, Y; Wanibuchi, H; Yoshimura, I | 1 |
2 other study(ies) available for 5-methylcytosine and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Combined 5-hydroxymethylcytosine content of human leucocyte antigen-B and human leucocyte antigen-DQB1 as novel biomarker for anti-tuberculosis drug-induced liver injury.
Topics: 5-Methylcytosine; Adult; Antitubercular Agents; Biomarkers; Case-Control Studies; Chemical and Drug Induced Liver Injury; DNA Methylation; Female; Genetic Predisposition to Disease; HLA-B Antigens; HLA-DQ beta-Chains; Humans; Male; Middle Aged; Tuberculosis | 2020 |
Existence of a no effect level for MeIQx hepatocarcinogenicity on a background of thioacetamide-induced liver damage in rats.
Topics: 5-Methylcytosine; Animals; Carcinogens; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; DNA Adducts; Dose-Response Relationship, Drug; Glutathione Transferase; Immunohistochemistry; Liver Diseases; Liver Neoplasms, Experimental; Male; Quinoxalines; Rats; Thioacetamide | 2006 |